Ciara Kennedy

Reneo

• Reneo is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic diseases including mitochondrial diseases.
• Cofounder: Niall O’Donnell (Rady MBA '06)
• Founded: 2014
• Funding Raised: $240M
• Company Status: IPO

Mirum

• Mirum develops and delivers therapies to address rare liver disease.
• Company Co-Founder(s): Niall O’Donnell (Rady MBA '06)
• Founded: 2019
• Funding Raised: $500M
• Company Status: IPO

Sorriso

• Sorriso is a clinical stage company focused on delivering the power of biologic therapies via oral medications to patients with chronic autoimmune diseases.
• Founded: 2021
• Funding Raised: $31M
• Currently Operational